Login / Signup

Treat-to-target dose reduction and withdrawal strategy of TNF inhibitors in psoriatic arthritis and axial spondyloarthritis: a randomised controlled non-inferiority trial.

Celia A J MichielsensNathan den BroederFrank Hj van den HoogenElien A M MahlerSteven TeerenstraDésirée Mfm van der HeijdeLise M VerhoefAlfons A den Broeder
Published in: Annals of the rheumatic diseases (2022)
NL 6771.
Keyphrases
  • study protocol
  • rheumatoid arthritis
  • disease activity
  • ankylosing spondylitis
  • phase iii
  • randomized controlled trial
  • clinical trial
  • phase ii
  • open label
  • systemic lupus erythematosus
  • double blind
  • placebo controlled